Showing results (161-170 of 214) with videos related to
Sort By:
Pageof 22
Cancer Treatment Reviews|January 1, 1993
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic resultsA H Calvert, M J Lind, M M Millward, et al.British Journal of Cancer|August 1, 1996
The relationship between tumour glutathione concentration, glutathione S-transferase isoenzyme expression and response to single agent carboplatin in epithelial ovarian cancer patientsS Ghazal-Aswad, L Hogarth, A G Hall, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2000
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell linesC A Delaney, L Z Wang, S Kyle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusionI Rafi, G A Taylor, J A Calvete, et al.British Journal of Cancer|September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein bindingN J Curtin, K J Bowman, R N Turner, et al.Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymeraseA W White, R Almassy, A H Calvert, et al.Cancer Chemotherapy and Pharmacology|September 6, 2000
Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)N Pavlidis, S Aamdal, A Awada, et al.Journal of Medicinal Chemistry|May 1, 1991
Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modificationsP R Marsham, L R Hughes, A L Jackman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2002
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III TrialL Biganzoli, T Cufer, P Bruning, et al.Seminars in Oncology|October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation studyA H Calvert, M J Lind, S Ghazal-Aswad, et al.Pageof 22